Ostatní
Návod 
Baxter International Inc.
BAX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
9.1B
Obrat
11B
Zisk
-1B
Aktiva
21B
Dluh
10B
ROE
0%
ROA
0%
PE
-9
PS
1
Cena 1R
17-38
⌀ Cena
24.86
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
19-02-2026
Poslední dividenda
27-02-2026
Profil
Baxter International Inc. prostřednictvím svých dceřiných společností vyvíjí a poskytuje portfolio zdravotnických produktů po celém světě. Společnost nabízí peritoneální dialýzu a hemodialýzu a další dialyzační terapie a služby; intravenózní terapie, infuzní pumpy, aplikační sety a přípravky pro rekonstituci léčiv; remixované a onkologické lékové platformy, inhalační anestezie a přípravky pro kritickou péči a kombinované lékárenské služby; parenterální nutriční terapie a související výrobky; biologické výrobky a zdravotnické prostředky používané při chirurgických zákrocích pro hemostázu, tkáňové těsnění a adhezní prevenci; a kontinuální terapie renální náhrady a další podpůrné terapie orgánů zaměřené na jednotku intenzivní péče. Poskytuje také propojená řešení péče, včetně zařízení, softwaru, komunikací a integračních technologií; integrované technologie pro monitorování a diagnostiku pacientů, které pomáhají diagnostikovat, léčit a zvládat různé nemoci a onemocnění, včetně respirační terapie, kardiologie, screeningu zraku a fyzického hodnocení; technologie chirurgického videa, stoly, světla, přívěsky, přesná polohovací zařízení a další příslušenství. Kromě toho společnost nabízí smluvní služby různým farmaceutickým a biofarmaceutickým společnostem. Jeho produkty jsou využívány v nemocnicích, centrech pro dialýzu ledvin, pečovatelských domech, rehabilitačních centrech, ordinacích lékařů a u pacientů doma pod dohledem lékaře. Společnost prodává své výrobky prostřednictvím přímých prodejců, jakož i prostřednictvím nezávislých distributorů, velkoobchodníků s drogami a specializovaných lékáren nebo jiných poskytovatelů alternativních lokalit v přibližně 100 zemích. Má dohodu s Celerity Pharmaceutical, LLC na vývoji generických injekčních premixů a onkolytických molekul pro akutní péči. Baxter International Inc. byla založena v roce 1931 a sídlí v Deerfieldu ve státě Illinois.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
38000
Založení
1981-10-27
Podobné společnosti
$ 145.13
+ $ 1.97
$ 487.29
- $ 1.97
$ 114.26
- $ 1.96
$ 148.98
+ $ 6.16
$ 69.78
- $ 0.06
$ 11.44
- $ 0.11
$ 120.02
- $ 3.67
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 11.24 | 11.24 | 10.64 | 14.81 | 15.11 | 12.78 | 11.67 | 11.36 | 11.13 | 10.56 | 10.16 | 9.97 | 16.67 | 15.26 | 14.19 | 13.89 | 12.84 | |
| Cost of Revenues | 7.87 | 7.87 | 6.65 | 9.84 | 9.72 | 7.68 | 7.09 | 6.60 | 6.35 | 6.09 | 6.05 | 5.82 | 8.51 | 7.66 | 6.89 | 6.85 | 6.89 | |
| Gross Profit | 3.38 | 3.38 | 3.98 | 4.98 | 5.40 | 5.11 | 4.59 | 4.76 | 4.78 | 4.47 | 4.11 | 4.15 | 8.16 | 7.60 | 7.30 | 7.05 | 5.96 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 2.97 | 2.84 | 2.81 | 2.63 | 2.75 | 2.70 | 2.69 | 2.49 | 3.89 | 3.71 | |
| Cost of Revenues | 2.40 | 1.89 | 1.82 | 1.76 | 1.79 | 1.67 | 1.66 | 1.53 | 2.41 | 2.59 | |
| Gross Profit | 0.58 | 0.95 | 0.99 | 0.86 | 0.96 | 1.03 | 1.03 | 0.96 | 1.47 | 1.12 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.67 | 0.61 | 0.53 | 0.52 | 0.60 | 0.66 | 0.61 | 0.65 | 0.60 | 1.42 | 1.25 | 1.16 | 0.95 | 0.92 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 3.94 | 3.89 | 2.87 | 2.47 | 3.29 | 2.62 | 2.60 | 2.74 | 3.09 | 4.03 | 3.68 | 3.32 | 3.15 | 2.91 | |
| Depreciation & Amortization | 0.98 | 0.98 | 1.00 | 1.26 | 1.40 | 0.89 | 0.82 | 0.79 | 0.79 | 0.76 | 0.80 | 0.76 | 1.01 | 0.82 | 0.71 | 0.67 | 0.69 | |
| Total Operating Expenses | 3.69 | 3.69 | 3.97 | 4.59 | 4.53 | 3.40 | 2.97 | 3.89 | 3.18 | 3.21 | 3.39 | 3.70 | 5.45 | 4.93 | 4.48 | 4.10 | 3.82 | |
| Operating Income | -0.31 | -0.31 | 0.01 | 0.39 | -0.55 | 0.78 | 0.60 | 0.98 | 1.60 | 1.29 | 0.72 | 0.45 | 2.56 | 2.67 | 2.82 | 2.95 | 2.14 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.17 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.94 | 1.00 | ||
| Depreciation & Amortization | 0.24 | 0.24 | 0.26 | 0.25 | 0.25 | 0.13 | 0.23 | 0.27 | 0.32 | 0.31 | ||
| Total Operating Expenses | 1.31 | 0.78 | 0.80 | 0.80 | 1.39 | 0.88 | 0.85 | 0.85 | 1.11 | 1.17 | ||
| Operating Income | -0.73 | 0.17 | 0.19 | 0.06 | -0.44 | 0.16 | 0.18 | 0.12 | 0.33 | -0.05 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.05 | 0.05 | 0.07 | 0.07 | 0.02 | 0.01 | 0.02 | 0.04 | 0.05 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.03 | |
| Interest Expense | 0.29 | 0.29 | 0.41 | 0.51 | 0.40 | 0.19 | 0.13 | 0.11 | 0.05 | 0.09 | 0.07 | 0.13 | 0.15 | 0.13 | 0.09 | 0.05 | 0.09 | |
| Other Expense | -0.20 | -0.20 | -0.30 | -0.49 | -1.80 | 0.70 | 0.69 | -0.01 | 0.14 | 0.01 | 4.30 | 0.11 | -0.12 | 0.01 | 0.16 | -0.08 | -0.16 | |
| IBT | -0.51 | -0.51 | -0.29 | -0.10 | -2.35 | 1.48 | 1.29 | 0.97 | 1.69 | 1.22 | 4.95 | 0.43 | 2.44 | 2.55 | 2.89 | 2.81 | 1.89 | |
| Income Tax Expense | 0.40 | 0.40 | 0.04 | -0.03 | 0.07 | 0.18 | 0.18 | -0.04 | 0.06 | 0.49 | -0.01 | 0.03 | 0.49 | 0.54 | 0.56 | 0.55 | 0.46 | |
| Net Income | -0.96 | -0.96 | -0.65 | 2.66 | -2.42 | 1.28 | 1.10 | 1.00 | 1.62 | 0.72 | 4.97 | 0.97 | 2.50 | 2.01 | 2.33 | 2.22 | 1.42 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.01 | ||
| Interest Expense | 0.07 | 0.07 | 0.07 | 0.08 | 0.10 | 0.10 | 0.10 | 0.10 | 0.12 | 0.13 | ||
| Other Expense | -0.03 | -0.05 | -0.06 | -0.06 | -0.09 | -0.09 | -0.06 | -0.07 | -0.09 | -0.12 | ||
| IBT | -0.76 | 0.12 | 0.13 | 0.00 | -0.52 | 0.07 | 0.12 | 0.05 | 0.24 | -0.17 | ||
| Income Tax Expense | 0.28 | 0.17 | 0.01 | -0.07 | -0.03 | 0.01 | 0.02 | 0.04 | 0.17 | -0.22 | ||
| Net Income | -1.13 | -0.05 | 0.09 | 0.13 | -0.51 | 0.14 | -0.31 | 0.04 | 0.25 | 2.51 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $5.25 | $-4.80 | $2.56 | $2.17 | $1.97 | $3.04 | $1.11 | $9.09 | $1.78 | $4.61 | $3.70 | $4.22 | $3.91 | $2.41 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $5.25 | $-4.80 | $2.53 | $2.13 | $1.93 | $2.97 | $1.08 | $9.01 | $1.76 | $4.56 | $3.66 | $4.18 | $3.88 | $2.39 | |
| Shares Outstanding | 0.51 | 0.51 | 0.51 | 0.51 | 0.50 | 0.50 | 0.51 | 0.51 | 0.53 | 0.54 | 0.55 | 0.55 | 0.54 | 0.54 | 0.55 | 0.57 | 0.59 | |
| Diluted Shares Outstanding | 0.51 | 0.51 | 0.51 | 0.51 | 0.50 | 0.51 | 0.52 | 0.52 | 0.55 | 0.56 | 0.55 | 0.55 | 0.55 | 0.55 | 0.56 | 0.57 | 0.59 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.50 | $-0.75 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.50 | $-0.75 | ||
| Shares Outstanding | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | ||
| Diluted Shares Outstanding | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 2.10 | 1.76 | 3.19 | 1.72 | 2.95 | 3.73 | 3.34 | 1.83 | 3.39 | 2.80 | 2.21 | 2.93 | 2.73 | 3.27 | 2.91 | 2.69 | |
| Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Cash & ST Investments | 2.10 | 1.76 | 3.19 | 1.72 | 2.95 | 3.73 | 3.34 | 1.83 | 3.39 | 2.80 | 7.36 | 2.93 | 2.73 | 3.27 | 2.91 | 2.69 | |
| Accounts Receivable | 2.69 | 1.73 | 2.74 | 2.75 | 2.71 | 2.08 | 1.90 | 1.81 | 1.79 | 1.69 | 1.73 | 2.80 | 2.91 | 2.43 | 2.42 | 2.27 | |
| Inventory | 2.99 | 2.05 | 2.82 | 2.72 | 2.45 | 1.92 | 1.65 | 1.65 | 1.48 | 1.43 | 1.60 | 3.56 | 3.50 | 2.80 | 2.63 | 2.37 | |
| Other Current Assets | 0.82 | 3.31 | 0.84 | 0.40 | 0.39 | 0.34 | 0.39 | 0.41 | 0.60 | 0.34 | 0.44 | 0.56 | 0.47 | 0.42 | 0.70 | 0.67 | |
| Total Current Assets | 8.59 | 8.85 | 9.60 | 8.01 | 8.87 | 8.41 | 7.50 | 5.92 | 7.26 | 6.57 | 11.80 | 10.35 | 10.00 | 9.26 | 8.65 | 7.99 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1.73 | 1.69 | 2.29 | 1.76 | 1.42 | 2.10 | 3.03 | 3.19 | 5.79 | 1.72 | |
| Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Cash & ST Investments | 1.73 | 1.69 | 2.29 | 1.76 | 1.42 | 2.10 | 3.03 | 3.19 | 5.79 | 1.72 | |
| Accounts Receivable | 1.78 | 1.77 | 1.65 | 1.73 | 1.73 | 2.64 | 2.52 | 2.74 | 2.51 | 2.50 | |
| Inventory | 2.46 | 2.38 | 2.17 | 2.05 | 2.10 | 2.99 | 2.99 | 2.82 | 2.87 | 2.90 | |
| Other Current Assets | 0.97 | 0.91 | 0.93 | 3.31 | 3.61 | 0.87 | 0.87 | 0.84 | 0.86 | 1.09 | |
| Total Current Assets | 6.93 | 6.75 | 7.04 | 8.85 | 8.86 | 8.59 | 9.40 | 9.60 | 12.03 | 8.21 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 4.84 | 3.18 | 4.96 | 5.53 | 5.81 | 5.33 | 5.12 | 4.54 | 4.59 | 4.29 | 4.39 | 8.70 | 7.83 | 6.10 | 5.53 | 5.26 | |
| Goodwill | 6.00 | 5.28 | 6.51 | 6.84 | 9.84 | 3.22 | 3.03 | 2.96 | 3.10 | 2.60 | 2.69 | 3.87 | 4.21 | 2.50 | 2.32 | 2.02 | |
| Intangible Assets | 5.74 | 5.22 | 6.08 | 6.79 | 7.79 | 1.67 | 1.47 | 1.40 | 1.37 | 1.11 | 1.35 | 2.08 | 2.29 | 0.81 | 0.83 | 0.50 | |
| Long-Term Investments | 0.17 | 0.11 | 0.19 | 0.25 | 0.15 | 0.14 | 0.08 | 0.17 | 0.19 | 0.18 | 0.18 | 0.13 | 0.22 | 0.15 | -0.30 | 0.16 | |
| Other Long-Term Assets | 0.97 | 2.94 | 0.55 | 0.58 | 0.68 | 0.51 | 0.37 | 0.19 | 0.19 | 0.17 | 0.23 | 0.52 | 0.44 | 0.41 | 1.76 | 0.43 | |
| Total Long-Term Assets | 17.72 | 16.93 | 18.68 | 20.28 | 24.65 | 11.61 | 10.69 | 9.72 | 9.85 | 8.97 | 9.18 | 15.57 | 15.87 | 11.13 | 10.42 | 9.50 | |
| Total Assets | 26.31 | 25.78 | 28.28 | 28.29 | 33.52 | 20.02 | 18.19 | 15.64 | 17.11 | 15.55 | 20.98 | 25.92 | 25.87 | 20.39 | 19.07 | 17.49 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3.08 | 3.09 | 3.02 | 3.18 | 3.16 | 4.84 | 4.90 | 4.96 | 4.80 | 5.03 | |
| Goodwill | 5.40 | 5.40 | 5.34 | 5.28 | 5.78 | 6.00 | 6.43 | 6.51 | 6.41 | 6.42 | |
| Intangible Assets | 4.81 | 4.95 | 5.08 | 5.22 | 5.45 | 5.74 | 5.91 | 6.08 | 6.23 | 6.47 | |
| Long-Term Investments | 0.00 | 0.11 | 0.12 | 0.11 | 0.13 | 0.17 | 0.17 | 0.19 | 0.19 | 0.20 | |
| Other Long-Term Assets | 0.85 | 0.75 | 0.72 | 2.94 | 3.29 | 0.97 | 0.98 | 0.55 | 1.19 | 1.77 | |
| Total Long-Term Assets | 14.13 | 14.30 | 14.27 | 16.93 | 17.81 | 17.72 | 18.39 | 18.68 | 18.62 | 19.68 | |
| Total Assets | 21.07 | 21.05 | 21.30 | 25.78 | 26.68 | 26.31 | 27.79 | 28.28 | 30.66 | 27.89 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.25 | 0.97 | 1.24 | 1.14 | 1.25 | 1.04 | 0.89 | 1.00 | 0.92 | 0.79 | 0.72 | 1.26 | 1.10 | 0.77 | 0.80 | 0.75 | |
| Short-Term Debt | 2.47 | 2.83 | 2.80 | 1.53 | 0.64 | 0.52 | 0.64 | 0.00 | 0.00 | 0.00 | 2.59 | 1.70 | 1.04 | 0.35 | 0.45 | 0.02 | |
| Other Current Liabilities | 2.23 | 2.36 | 2.05 | 1.92 | 2.19 | 1.77 | 1.70 | 1.59 | 1.67 | 0.00 | 0.05 | 3.07 | 3.00 | 2.77 | 2.88 | 2.93 | |
| Current Liabilities | 6.13 | 6.51 | 6.50 | 4.75 | 4.24 | 3.33 | 3.23 | 2.84 | 2.82 | 2.74 | 5.75 | 6.04 | 5.91 | 4.76 | 4.86 | 4.04 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.95 | 1.00 | 0.96 | 0.97 | 0.84 | 1.25 | 1.33 | 1.24 | 1.25 | 1.24 | |
| Short-Term Debt | 0.76 | 0.01 | 0.66 | 2.83 | 2.50 | 2.47 | 2.63 | 2.80 | 2.43 | 2.18 | |
| Other Current Liabilities | 2.07 | 1.94 | 1.86 | 2.36 | 2.86 | 2.41 | 2.40 | 1.90 | 2.54 | 2.35 | |
| Current Liabilities | 3.78 | 2.94 | 3.48 | 6.51 | 6.20 | 6.13 | 6.37 | 6.50 | 6.21 | 5.77 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 10.44 | 10.62 | 11.57 | 15.69 | 17.67 | 6.29 | 5.32 | 3.47 | 3.51 | 2.78 | 3.94 | 7.61 | 8.13 | 5.58 | 4.75 | 4.36 | |
| Capital Leases | 0.44 | 0.32 | 0.57 | 0.58 | 0.65 | 0.61 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.44 | 0.10 | 0.45 | 0.70 | 0.96 | 0.14 | 0.19 | 0.21 | 0.28 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 18.60 | 18.76 | 19.81 | 22.39 | 24.40 | 11.29 | 10.28 | 7.83 | 8.00 | 7.27 | 12.11 | 17.76 | 17.38 | 13.41 | 12.25 | 10.69 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 8.96 | 9.72 | 9.65 | 10.62 | 10.70 | 10.88 | 11.54 | 11.57 | 14.50 | 14.74 | |
| Capital Leases | 0.21 | 0.23 | 0.24 | 0.32 | 0.26 | 0.44 | 0.44 | 0.57 | 0.44 | 0.44 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 | 0.45 | -0.04 | -0.04 | |
| Total Liabilities | 13.85 | 13.75 | 14.25 | 18.76 | 18.73 | 18.60 | 19.55 | 19.81 | 22.49 | 22.25 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | |
| Retained Earnings | 15.54 | 14.93 | 16.11 | 14.05 | 17.07 | 16.33 | 15.72 | 15.63 | 14.48 | 14.20 | 9.68 | 13.23 | 11.85 | 10.89 | 9.43 | 7.93 | |
| Comprehensive Income | -3.83 | -4.01 | -3.55 | -3.83 | -3.38 | -3.31 | -3.71 | -4.42 | -4.00 | -4.56 | 0.22 | -3.65 | -1.98 | -2.81 | -2.59 | -2.14 | |
| Total Common Equity | 7.64 | 6.96 | 8.40 | 5.83 | 9.08 | 8.69 | 7.88 | 7.79 | 9.12 | 8.29 | 8.85 | 8.12 | 8.46 | 6.94 | 6.59 | 6.57 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | |
| Retained Earnings | 14.84 | 14.97 | 14.97 | 14.93 | 15.53 | 15.54 | 16.00 | 16.11 | 16.02 | 13.66 | |
| Comprehensive Income | -3.73 | -3.75 | -3.94 | -4.01 | -3.65 | -3.83 | -3.72 | -3.55 | -3.72 | -3.81 | |
| Total Common Equity | 7.24 | 7.32 | 7.08 | 6.96 | 7.87 | 7.64 | 8.17 | 8.40 | 8.10 | 5.57 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 13.34 | 13.45 | 14.36 | 17.21 | 18.31 | 6.80 | 5.96 | 3.48 | 3.51 | 2.78 | 6.52 | 9.31 | 9.17 | 5.93 | 5.20 | 4.39 | |
| Book Value | 7.71 | 7.02 | 8.47 | 5.90 | 9.12 | 8.73 | 7.91 | 7.82 | 9.12 | 8.28 | 8.87 | 8.16 | 8.49 | 6.98 | 6.83 | 6.80 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | -0.03 | -0.03 | -0.03 | 0.06 | 0.07 | 0.07 | 0.06 | 0.07 | 0.07 | 0.06 | |
| Book Value | 7.24 | 7.32 | 7.08 | 6.96 | 7.87 | 7.64 | 8.17 | 8.40 | 8.10 | 5.57 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -0.15 | -0.96 | -0.33 | -0.08 | -2.42 | 1.30 | 1.11 | 1.01 | 1.63 | 0.72 | 4.97 | 0.39 | 2.50 | 2.01 | 2.33 | 2.26 | 1.43 | |
| Depreciation & Amortization | 1.26 | 0.98 | 1.00 | 1.26 | 1.40 | 0.89 | 0.82 | 0.79 | 0.79 | 0.76 | 0.80 | 0.76 | 1.01 | 0.82 | 0.71 | 0.67 | 0.69 | |
| Stock-Based Compensation | 0.12 | 0.12 | 0.11 | 0.13 | 0.15 | 0.15 | 0.13 | 0.12 | 0.12 | 0.11 | 0.12 | 0.13 | 0.16 | 0.15 | 0.13 | 0.12 | 0.12 | |
| Change Working Capital | -0.32 | -0.11 | -0.24 | 0.27 | -1.02 | -0.16 | -0.27 | -0.43 | -0.36 | -0.18 | -0.18 | -0.32 | -0.66 | -0.25 | -0.30 | -0.79 | -0.37 | |
| Change In Accounts Receivable | -0.19 | -0.13 | -0.04 | -0.07 | -0.15 | -0.17 | -0.13 | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 | -0.13 | 0.00 | -0.04 | -0.23 | -0.12 | |
| Change In Accounts Payable | 0.01 | 0.00 | 0.11 | 0.11 | -0.08 | 0.10 | 0.14 | -0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.02 | 0.10 | -0.01 | |
| Change In Inventories | -0.13 | -0.12 | -0.20 | -0.11 | -0.36 | -0.04 | -0.16 | 0.00 | -0.20 | 0.08 | 0.08 | -0.12 | -0.44 | -0.31 | -0.13 | -0.32 | 0.02 | |
| Other Non-cash Items | 2.23 | 0.74 | 0.73 | 0.64 | 3.32 | 0.20 | 0.17 | 0.92 | 0.19 | 0.22 | -3.78 | 0.74 | 0.30 | 0.68 | 0.25 | 0.39 | 1.06 | |
| Cash from Operations | 1.17 | 0.00 | 0.00 | 1.73 | 1.21 | 2.22 | 1.87 | 2.10 | 2.10 | 1.84 | 1.62 | 1.65 | 3.22 | 3.20 | 3.11 | 2.82 | 3.00 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1.04 | -0.05 | 0.12 | 0.06 | -0.49 | 0.43 | -0.28 | 0.01 | 0.07 | 0.05 | |
| Depreciation & Amortization | 0.24 | 0.24 | 0.26 | 0.25 | 0.25 | 0.13 | 0.35 | 0.27 | 0.32 | 0.31 | |
| Stock-Based Compensation | 0.04 | 0.04 | 0.04 | 0.01 | 0.04 | 0.02 | 0.04 | 0.02 | 0.03 | 0.04 | |
| Change Working Capital | 0.40 | -0.03 | -0.18 | -0.30 | 0.28 | -0.07 | -0.28 | -0.17 | 0.05 | 0.08 | |
| Change In Accounts Receivable | -0.09 | 0.00 | -0.07 | 0.03 | -0.02 | 0.01 | -0.15 | 0.13 | -0.12 | -0.05 | |
| Change In Accounts Payable | 0.04 | -0.06 | 0.01 | 0.02 | 0.11 | -0.06 | -0.06 | 0.12 | -0.03 | -0.02 | |
| Change In Inventories | 0.24 | -0.08 | -0.16 | -0.12 | -0.02 | 0.05 | -0.08 | -0.15 | 0.10 | -0.01 | |
| Other Non-cash Items | 0.75 | -0.01 | 0.01 | -0.07 | 0.54 | -0.26 | 0.36 | 0.09 | -0.04 | 0.33 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.53 | 0.37 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.66 | -0.51 | -0.46 | -0.69 | -0.68 | -0.74 | -0.71 | -0.70 | -0.68 | -0.63 | -0.72 | -0.91 | -1.90 | -1.53 | -1.16 | -0.96 | -0.96 | |
| Acquisitions | -0.01 | 0.00 | 0.00 | -0.01 | -0.26 | -10.50 | -0.49 | -0.42 | -0.26 | -0.68 | -0.01 | 0.05 | 0.36 | -3.84 | -0.41 | -0.59 | -0.32 | |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales of Investment | 0.03 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 3.95 | 0.00 | 0.00 | 3.91 | 0.01 | 0.05 | 0.02 | 0.01 | 0.00 | 0.00 | -0.66 | -0.95 | 0.00 | 0.00 | 0.00 | 0.12 | 0.02 | |
| Cash from Investing | 3.30 | 0.00 | 0.00 | 3.21 | -0.93 | -11.20 | -1.18 | -1.10 | -0.94 | -1.31 | -0.72 | -1.81 | -1.54 | -5.36 | -1.57 | -1.43 | -1.26 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.14 | -0.11 | -0.15 | -0.12 | -0.14 | -0.02 | -0.19 | -0.11 | -0.19 | -0.17 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales of Investment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 | 3.96 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.23 | 3.79 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -3.27 | 0.00 | 0.00 | -2.93 | -0.95 | -2.82 | -1.41 | 0.00 | -0.01 | 0.00 | -1.40 | -3.78 | -1.03 | -0.54 | -0.02 | -0.02 | -0.57 | |
| Debt Issued | -0.31 | 13.45 | -0.92 | 0.08 | -0.14 | 14.33 | 2.25 | 2.48 | -0.03 | 0.73 | -2.34 | 0.99 | 1.17 | 3.78 | 0.76 | 0.83 | 4.95 | |
| Issuance of Common Stock | 0.09 | 0.00 | 0.00 | 0.10 | 0.00 | 12.34 | 2.09 | 0.00 | 0.26 | 0.98 | 1.67 | 0.00 | 1.29 | 4.14 | 1.30 | 0.76 | 0.66 | |
| Repurchase of Common Stock | -0.04 | 0.00 | 0.00 | -0.10 | -0.03 | -0.60 | -0.50 | -1.27 | -2.45 | -0.56 | -0.29 | 0.00 | -0.55 | -0.91 | -1.48 | -1.58 | -1.45 | |
| Dividends Paid | -0.59 | 0.00 | 0.00 | -0.59 | -0.57 | -0.53 | -0.47 | -0.42 | -0.38 | -0.32 | -0.27 | -0.91 | -1.10 | -1.02 | -0.80 | -0.71 | -0.69 | |
| Other Financing Activities | -0.27 | 0.00 | 0.00 | 0.03 | 0.12 | -0.14 | -0.05 | 2.19 | -0.03 | -0.04 | -0.03 | 4.33 | -0.01 | -0.02 | -0.11 | 0.42 | 0.33 | |
| Cash from Financing | -4.07 | 0.00 | 0.00 | -3.49 | -1.44 | 8.25 | -0.35 | 0.50 | -2.60 | 0.06 | -0.32 | -0.36 | -1.40 | 1.65 | -1.12 | -1.14 | -1.72 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.79 | 0.05 | |
| Debt Issued | 9.71 | -0.01 | -0.58 | -3.14 | 0.26 | -0.15 | -0.83 | -0.19 | 0.23 | 0.06 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.03 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.15 | -0.15 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.94 | -0.06 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.37 | -0.45 | -0.78 | 1.48 | -1.23 | -0.78 | 0.40 | 1.50 | -1.56 | 0.59 | 0.59 | -0.71 | 0.19 | -0.54 | 0.37 | 0.22 | -0.10 | |
| Closing Cash Balance | 2.10 | 1.97 | 2.41 | 3.20 | 1.72 | 2.96 | 3.74 | 3.34 | 1.83 | 3.39 | 2.80 | 2.21 | 2.93 | 2.73 | 3.27 | 2.91 | 2.69 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.24 | 0.04 | -0.61 | -0.12 | 0.33 | -0.02 | -0.93 | -0.17 | -2.59 | 4.07 | |
| Closing Cash Balance | 1.97 | 1.73 | 1.69 | 2.30 | 2.41 | 2.08 | 2.10 | 3.03 | 3.20 | 5.79 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.52 | 0.32 | 0.56 | 1.03 | 0.53 | 1.48 | 1.16 | 1.41 | 1.42 | 1.20 | 0.91 | 0.74 | 1.32 | 1.67 | 1.95 | 1.86 | 2.04 | |
| Real Free Cash Flow | 0.39 | 0.21 | 0.45 | 0.90 | 0.38 | 1.33 | 1.03 | 1.29 | 1.30 | 1.10 | 0.79 | 0.61 | 1.16 | 1.52 | 1.82 | 1.74 | 1.92 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.44 | 0.13 | 0.07 | -0.32 | 0.35 | 0.23 | -0.07 | 0.05 | 0.34 | 0.19 | |
| Real Free Cash Flow | 0.41 | 0.09 | 0.03 | -0.33 | 0.31 | 0.21 | -0.11 | 0.04 | 0.31 | 0.15 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -8.7 | 19.7 | 1703.4 |
| P/S | 0.7 | 2.7 | 67.9 |
| P/B | 1.2 | 4.1 | 25.8 |
| P/FCF | 40.3 | 58.3 | 396.3 |
| Market cap | $9.1 | $19.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 34.7 % | 0 % |
| Debt to Income | -1014.8 % | 340.3 % | 0 % |
| Debt to Free cash flow | 4714.6 % | 18.9 % | 0 % |
| Interest expense percentage | -94.2 % | -14.3 % | 38.7 % |
| Current ratio | 1.8 | 2.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -13.2 % | 17.2 % | 0 % |
| ROA | -4.5 % | 7.4 % | 0 % |
| CapEx to Revenue | 4.6 % | 6.6 % | 10.6 % |
| RaD to Revenue | 0 % | 5.9 % | 0 % |
| ROEM | 295,894.7 | 213752.1 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 33 % | 43.2 % | 79.8 % |
| Operating margin | 6.1 % | 12.2 % | 29.6 % |
| Net margin | -7.7 % | 11.5 % | 27.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 2 % | 0 % |
| Dividend payout percentage | 0 % | 15.7 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 514.0 mil | 537.6 mil |
| Employee count | 38.0 tis | 50.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
